CTRI/2013/07/003810已完成未知
Pharmacodynamic interaction study of Emblica officinalis (CAPROS)with clopidogrel and ecosprin in patients with type II diabetes mellitus.
AYUSH0 个研究点目标入组 10 人开始时间: 待定最近更新:
相关药物
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients of either gender between 30-70 yrs, on stable dose of anti-diabetic medication (taking Metformin alone in dose between 1000-2500mg per day or in combination with glimiperide maximum 4 mg per day) as prescribed by the physician over past 8 weeks prior to screening visit and having HbA1c between 6.5-8% were enrolled in the study.
排除标准
- •To avoid factors known to affect antiplatelet activity, the following exclusion criteria were applied: severe uncontrolled hyperglycemia, uncontrolled hypertension, cardiac arrhythmia, congestive heart failure, and evidence of hepatic and renal impairment or any other serious chronic disease requiring active treatment. Subjects hypersensitive to the study drugs were also excluded.
研究者
相似试验
已完成
3 期
Effect of Empagliflozin in prevention of kidney stone parametersIRCT20211203053261N2Hamedan University of Medical Sciences138
招募中
3 期
Effects of Coadministration of Empagliflozin and Colchicine on Heart Failure.IRCT20111206008307N40Tabriz University of Medical Sciences50
已完成
不适用
The pharmacokinetics and pharmacodynamics of eculizumab in patients with paroxysmal nocturnal hemoglobinuria.PNHrare blood disease10018849NL-OMON48010Radboud Universitair Medisch Centrum27
进行中（未招募）
不适用
Study on the pharmacodynamic interactions between propofol and sevoflurane during induction of anesthesia.AnesthesiaEUCTR2005-004632-40-BEniversity Hospital Ghent60
招募中
3 期
Effect of Empagliflozin in PrediabetesCondition 1: Impaired fasting glucose. Condition 2: Impaired glucose tolerance.Impaired fasting glucoseImpaired glucose tolerance (oral)R73.01R73.02IRCT20220902055858N1Shahre-kord University of Medical Sciences90